INS and diabetes mellitus: PDAC-DM can resemble recent-onset type 2 diabetes early on, so dynamic testing may be required to uncover low β-cell output, higher insulin clearance, and inadequate postprandial glucagon suppression (α-cell dysregulation) [8].